World renown George Clinical Scientific Leaders, researchers and project operations teams will be attending the International Society of Nephrology (ISN) World Congress of Nephrology (WCN) in Abu Dhabi March 26 – 29, 2020.
Four of our Scientific Leaders will be attending the ISN Conference:
This annual educational event of the ISN WCN will be hosted together with the Emirates Medical Association of Nephrology Society (EMAN). The WCN features regionally relevant symposia, presentations, training programs and courses. A range of topics will be covered related to nephrology. In addition, the conference provides an opportunity for experts and peers to network and share best practices.
Will you be attending ISN this year? Get in touch with Jeremy Xie today at [email protected] for more information and to arrange a meeting with our scientific leaders.
Dr. Jha focuses on understanding the global societal impact of kidney diseases and development of affordable, scalable and sustainable prevention tools. He is Executive Director, The George Institute for Global Health, India; Professor and Chair of Global Kidney Health, Imperial College, London; Conjoint Professor of Medicine, University of New South Wales; Professor, Prasanna School of Public Health, Manipal Academy of Higher Education, India; and Immediate Past President (2019 – 2021) International Society of Nephrology. He has led research projects in more than 20 countries and has worked with many organizations including WHO to develop clinical practice guidelines and advocacy papers.
Dr. Wong is a clinical trialist with interests in strategies to delay CKD progression, biomarkers research, randomized controlled clinical trials and translational research. He is Associate Professor of Medicine, University of Sydney, Researcher and Educator, and a Senior Consultant Nephrologist and Director of Renal Research at the Department of Renal Medicine, Concord Repatriation General Hospital. He is a Council member of the Asia Pacific Society of Nephrology (APSN), and the Honorary Executive Officer of the Australia New Zealand Society of Nephrology (ANZSN).
Dr. Wheeler’s research focuses on CKD and its complications, specifically those that increase cardiovascular disease burden and/or accelerate kidney failure progression. He heads a clinical research team at the Royal Free Hospital in London and is Professor of Kidney Medicine at University College London. He has been involved in the development of Clinical Practice Guidelines for Kidney Disease: Improving Global Outcomes (KDIGO) and was KDIGO co-chair between 2012 and 2019.
Abu Dhabi National Exhibition Center (ADNEC)
Khaleej Al Arabi Street
Abu Dhabi, UAE
United Arab Emirates
Meet with George Clinical! Contact us to schedule a time now.
